GPR55 and cancer: Functionally, GPR55 contributes to cancer progression by activating ERK signaling, which promotes proliferation, and by inducing AKT phosphorylation, a key driver of survival pathways in ovarian carcinoma (OVCAR-3) and prostate cancer cells [29].